Hims & Hers Health, Inc.
HIMS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,476,514 | $872,000 | $526,916 | $271,878 |
| % Growth | 69.3% | 65.5% | 93.8% | – |
| Cost of Goods Sold | $303,379 | $157,051 | $118,194 | $67,384 |
| Gross Profit | $1,173,135 | $714,949 | $408,722 | $204,494 |
| % Margin | 79.5% | 82% | 77.6% | 75.2% |
| R&D Expenses | $78,819 | $48,227 | $29,237 | $22,379 |
| G&A Expenses | $167,767 | $129,883 | $98,192 | $113,662 |
| SG&A Expenses | $846,611 | $576,318 | $370,779 | $249,564 |
| Sales & Mktg Exp. | $678,844 | $446,435 | $272,587 | $135,902 |
| Other Operating Expenses | $185,802 | $119,857 | $77,403 | $47,593 |
| Operating Expenses | $1,111,232 | $744,402 | $477,419 | $319,536 |
| Operating Income | $61,903 | -$29,453 | -$68,697 | -$115,042 |
| % Margin | 4.2% | -3.4% | -13% | -42.3% |
| Other Income/Exp. Net | $9,808 | $7,882 | $2,988 | $4,247 |
| Pre-Tax Income | $71,711 | -$21,571 | -$65,709 | -$110,795 |
| Tax Expense | -$54,327 | $1,975 | -$31 | -$3,136 |
| Net Income | $126,038 | -$23,546 | -$65,678 | -$107,659 |
| % Margin | 8.5% | -2.7% | -12.5% | -39.6% |
| EPS | 0.58 | -0.11 | -0.32 | -0.58 |
| % Growth | 627.3% | 65.6% | 44.8% | – |
| EPS Diluted | 0.53 | -0.11 | -0.32 | -0.58 |
| Weighted Avg Shares Out | 215,939 | 209,345 | 204,516 | 186,782 |
| Weighted Avg Shares Out Dil | 236,809 | 209,345 | 204,516 | 186,782 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $17,088 | $9,515 | $7,474 | $4,075 |
| EBITDA | $78,991 | -$19,938 | -$61,223 | -$110,967 |
| % Margin | 5.3% | -2.3% | -11.6% | -40.8% |